Related Party Transactions (Details Narrative)									1 Months Ended						3 Months Ended		6 Months Ended		11 Months Ended
	May 11, 2017 $ / shares shares	Mar. 01, 2017 shares	Feb. 10, 2017 shares	Feb. 02, 2017 shares	Jan. 10, 2017 shares	Sep. 09, 2016 USD ($) $ / shares shares	Feb. 02, 2016 USD ($) $ / shares shares	May 01, 2015 USD ($) Installment	Jun. 28, 2017 USD ($) $ / shares shares	Mar. 01, 2017 shares	Feb. 28, 2017 shares	Feb. 23, 2017 USD ($)	Feb. 17, 2017 shares	Sep. 25, 2014 USD ($) Installment	Jun. 30, 2017 USD ($) $ / shares	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) $ / shares	Jun. 30, 2016 USD ($) $ / shares	May 11, 2018 $ / shares	Dec. 31, 2016 USD ($)	Mar. 15, 2016 shares
Stock option grant vested | $ / shares																	$ 3.38	$ 1.40	$ 37,500
Accounts payable															$ 65,506		$ 65,506			$ 33,290
Research and development expense															$ 144,885	$ 73,810	$ 223,965	$ 185,632
Exercise Price | $ / shares															$ 3.09		$ 3.09
Charitable Grant Agreement [Member]
Donation to the University														$ 75,000
Donation periodic payment														$ 9,375
Number of installments | Installment														8
Joseph Sierchio [Member] | Stock option [Member]
Common stock shares reserved under stock option plan | shares			70,000
Debt conversion converted instrument shares issued | shares			38,642
Joseph Sierchio [Member] | Loan agreement [Member]
Convertible debt financing, Loan received												$ 25,000
Interest rate												7.00%
Maturity date												Feb. 23, 2018
Debt instrument conversion feature												(i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.
KCC [Member] | Loan agreement [Member]
Convertible debt financing, Maximum amount						$ 900,000
Convertible debt financing, Loan received						700,000						$ 395,000
Convertible debt financing, Remaining amount						$ 200,000
Interest rate						7.00%						7.00%
Maturity date						Dec. 31, 2017						Feb. 23, 2018
Debt instrument conversion feature						(i) $1.54; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to convert the Note, subject to a floor price of $1.23.						(i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder(s) elect to convert the February 2017 Note(s), subject to a floor price of $2.76.
Debt instrument floor price | $ / shares						$ 1.23
StemCell Systems [Member]
Incurred expenses															$ 52,830	36,000	$ 106,830	110,567
Satterlee Stephens LLP [Member]
Accounts payable																				11,750
Kenneth Kirkland [Member] | Stock option [Member]
Common stock shares reserved under stock option plan | shares				40,000
Debt conversion converted instrument shares issued | shares				29,642
Thomas bold [Member] | Stock option [Member]
Common stock shares reserved under stock option plan | shares													40,000
Debt conversion converted instrument shares issued | shares													34,296
Series F Warrant [Member] | Joseph Sierchio [Member] | Loan agreement [Member]
Common stock shares reserved under stock option plan | shares											7,246
Debt instrument conversion feature											(i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.
Warrant expiration period											5 years
Series F Warrant [Member] | KCC [Member]
Debt conversion converted instrument shares issued | shares									114,493
Exercise Price | $ / shares									$ 3.01
Proceeds from issuance of common stock									$ 344,624
Series F Warrant [Member] | KCC [Member] | Loan agreement [Member]
Common stock shares reserved under stock option plan | shares											114,493
Debt instrument conversion feature											(i) $3.45; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which the Holder elects to exercise their Series F Warrant.
Warrant expiration period											5 years
Series B Warrant [Member] | KCC [Member]
Common stock shares reserved under stock option plan | shares		1,326,087								1,326,087
Debt conversion converted instrument shares issued | shares		1,181,194					2,173,913			1,326,087
Exercise Price | $ / shares							$ 0.46
Proceeds from issuance of common stock							$ 1,000,000
Series E Warrant [Member] | KCC [Member] | Loan agreement [Member]
Common stock shares reserved under stock option plan | shares						584,416
Debt instrument conversion feature						(i) $1.54; or (ii) a 20% discount to the average closing price of the Company’s common stock for the five days prior to the date on which KCC elects to exercise the Series E Warrant.
Warrant expiration period						5 years
Series B and C warrants [Member] | KCC [Member]
Debt conversion converted instrument shares issued | shares		4,273,831
Series C Warrant [Member] | KCC [Member]
Common stock shares reserved under stock option plan | shares		3,500,000								3,500,000
Debt conversion converted instrument shares issued | shares		3,092,637								3,092,637
Dr. Gerlach [Member]
Compensation expense for services															8,460	12,060	18,540	23,940
Accounts payable															8,460		8,460			18,540
Dr. Gerlach [Member] | Option agreement [Member]
Number of installments | Installment								4
Fees payable under agreement								$ 24,000
Due to related party periodic payment								6,000
Research and development expense								$ 24,000
Dr. Gerlach [Member] | Series A [Member]
Common stock shares reserved under stock option plan | shares					240,000
Debt conversion converted instrument shares issued | shares					204,571
Joseph Sierchio [Member]
Annual retainer payable															6,000		$ 6,000
Common stock shares reserved under stock option plan | shares	75,000																				50,000
Exercise price | $ / shares	$ 4.20																$ 1.91
Legal fees															77,537	$ 54,665	$ 180,668	$ 91,515
Accounts payable															40,000		40,000			$ 11,750
Kenneth Kirkland [Member]
Annual retainer payable															$ 6,000		$ 6,000
Common stock shares reserved under stock option plan | shares	75,000																				50,000
Exercise price | $ / shares	$ 4.20																$ 1.91